Venky RaghavanExecutive Director, Search & Evaluation, Oncology at NovartisSpeaker
Profile
Venky Raghavan is an Executive Director in Oncology at Novartis, where he leads Search & Evaluation for prostate and breast cancer. In this role, he is responsible for identifying and evaluating external innovation opportunities across modalities and development stages, supporting oncology portfolio strategy from early discovery through clinical development.
He has over 12 years of experience in the biopharma industry spanning strategy consulting, global marketing, and business development. Prior to Novartis, he held roles at Bayer in global marketing and subsequently in Business Development & Licensing. Earlier in his career, he worked in life sciences strategy consulting at Oliver Wyman and IQVIA, advising biopharmaceutical companies on portfolio strategy and growth initiatives.
He holds a PhD in molecular biology from the University of Pittsburgh School of Medicine and brings a strong scientific foundation to oncology-focused external innovation, asset evaluation, and strategic decision‑making.
Agenda Sessions
Big Pharma’s Perspective: What Are They Looking for in Biotech Partners?
, 11:45amView Session
